RevMed
Home/Brands/MTS Medical AG

MTS Medical AG

7 Results
Results Per Page
  • 50
  • 100
  • 250
Catalog #
Qty
Starting At
Name
Company Name
Description
0
-
MTS
MTS Medical AG
The LithoGold® is a compact mobile unit for extracorporeal shock wave lithotripsy in urology. Brand Name device: LithoGold® Brand Facility: MTS
0
-
Dermagold100
MTS Medical AG
The OW100S is indicated to provide acoustic pressure shockwave in the treatment of chronic, full-thickness diabetic foot ulcer with wound area measuring no larger than 16 cm2, which extend through the epidermis, dermis, tendon, or capsule, but without bone exposure. The OW100S is indicated for adult (22 year and older), diabetic patients presenting with diabetic foot ulcers greater than 30 days in duration and is indicated for use in conjunction with standard diabetic ulcer care. The OW100S is indicated to provide acoustic pressure shockwaves in the treatment of superficial partial thickness second degree burns in adults (22 year or older). The OW100S is indicated for use in conjunction with standard of care burn treatment(s).
0
-
VIASURE
MTS Medical AG
Indications for UseThe VIASURE is intended for :• Relief of minor muscle aches and pains• Temporary increase in local blood circulation• Activation of connective tissue
0
-
DermaGold100®
MTS Medical AG
The DermaGold100® is intended for treatment of - diabetic footulcers- superficial partial thickness second degree burns in adults (22 years and older). The dermagold100 is indicated for use in conjunction with standard of care burn treatment(s)
0
-
OW100S
MTS Medical AG
Indications for Use The OW100S (model OW100S-US) is intended for:- Relief of minor muscle aches and pains- Temporary increase in local blood circulation- Activation of connective tissue
0
-
OrthoGold100®
MTS Medical AG
Indications for UseThe OrthoGold100® is intended for :• Relief of minor muscle aches and pains• Temporary increase in local blood circulation• Activation of connective tissue
0
-
Softwave Gold Li
MTS Medical AG
The OW100S-US is indicated to provide acoustic pressure shockwaves in the treatment of chronic, full-thickness diabetic foot ulcers with wound areas measuring no larger than 16 cm2, which extend through the epidermis, dermis, tendon, or capsule, but without bone exposure. OW100S-US is indicated for adult (22 years and older), diabetic patients presenting with diabetic foot ulcers greater than 30 days in duration and is indicated for use in conjunction with standard diabetic ulcer care.The OW100S-US is indicated to provide acoustic pressure shockwaves in the treatment of superficial partial thickness second degree burns in adults (22 years or older). The OW100S-US is indicated for use in conjunction with standard of care burn treatment(s)